Overall HYPR gets a fundamental rating of 3 out of 10. We evaluated HYPR against 186 industry peers in the Health Care Equipment & Supplies industry. The financial health of HYPR is average, but there are quite some concerns on its profitability. HYPR is valied quite expensively at the moment, while it does show a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -96.49% | ||
| ROE | -149.05% | ||
| ROIC | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.12% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -9.49 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.63 | ||
| Quick Ratio | 3.06 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
0.98
+0.07 (+7.69%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 8.99 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.54 | ||
| P/tB | 3.54 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -96.49% | ||
| ROE | -149.05% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 46.12% | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 108.34% | ||
| Cap/Sales | 10.67% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.63 | ||
| Quick Ratio | 3.06 | ||
| Altman-Z | -9.49 |
ChartMill assigns a fundamental rating of 3 / 10 to HYPR.
ChartMill assigns a valuation rating of 0 / 10 to HYPERFINE INC (HYPR). This can be considered as Overvalued.
HYPERFINE INC (HYPR) has a profitability rating of 0 / 10.
The financial health rating of HYPERFINE INC (HYPR) is 6 / 10.
The Earnings per Share (EPS) of HYPERFINE INC (HYPR) is expected to grow by 17.13% in the next year.